Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

NCT: NCT06384599 · NOT_YET_RECRUITING

NCT IDNCT06384599
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2027-09-01

Brief Summary

The PMCF is a prospective, single-arm, multi-center, controlled study of up to 130 patients designed to collect safety and performance data regarding the use of the Adagio VT Cryoablation System in the treatment of recurrent ventricular tachycardia.

Frequently Asked Questions

What is VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study?

VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study is a clinical trial registered under NCT06384599. Current status: NOT_YET_RECRUITING.

What is the status of NCT06384599?

The current status of NCT06384599 (VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study) is: NOT_YET_RECRUITING.

When did VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study start?

VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study started on 2026-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑